Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
Article ID | PMID | Source | Title | Publish Year | |
---|---|---|---|---|---|
A21082 | 25544876 | World J Hepatol | Transitions of histopathologic criteria for diagnosis of nonalcoholic fatty liver disease during the last three decades. | 2014 | Details |
A21083 | 25544875 | World J Hepatol | Involvement of the TAGE-RAGE system in non-alcoholic steatohepatitis: Novel treatment strategies. | 2014 | Details |
A21084 | 25544867 | Oxid Med Cell Longev | Dietary blueberry and bifidobacteria attenuate nonalcoholic fatty liver disease in rats by affecting SIRT1-mediated signaling pathway. | 2014 | Details |
A21085 | 25544409 | Rev Esp Enferm Dig | Insulin resistance and metabolic syndrome are related to non-alcoholic fatty liver disease, but not visceral adiposity index, in severely obese patients. | 2014 | Details |
A21087 | 25543522 | Clin Res Hepatol Gastroenterol | Nonalcoholic fatty liver disease (NAFLD) without insulin resistance: Is it different? | 2014 | Details |
A21088 | 25543202 | Alcohol | A comparison of the cardiometabolic profile of black South Africans with suspected non-alcoholic fatty liver disease (NAFLD) and excessive alcohol use. | 2014 | Details |
A21089 | 25542756 | Eur J Pharmacol | Ameliorative effect of nicorandil on high fat diet induced non-alcoholic fatty liver disease in rats. | 2014 | Details |
A21090 | 25541989 | PLoS One | LDL-migration index (LDL-MI), an indicator of small dense low-density lipoprotein (sdLDL), is higher in non-alcoholic steatohepatitis than in non-alcoholic fatty liver: a multicenter cross-sectional study. | 2014 | Details |
A21091 | 25541279 | Prostaglandins Leukot Essent Fatty Acids | Ameliorative potential of omega 3 fatty acids and HMG-CoA reductase inhibitors on experimentally-induced non-alcoholic steatohepatitis. | 2014 | Details |
A21092 | 25540973 | Scand J Gastroenterol | Characterization of lean patients with nonalcoholic fatty liver disease: potential role of high hemoglobin levels. | 2014 | Details |
A21093 | 25540128 | Dis Model Mech | In vitro treatment of HepG2 cells with saturated fatty acids reproduces mitochondrial dysfunction found in nonalcoholic steatohepatitis. | 2014 | Details |
A21094 | 25540086 | Dig Dis Sci | The evaluation of hepatic fibrosis scores in children with nonalcoholic fatty liver disease. | 2014 | Details |
A21095 | 25539480 | Med Sci Sports Exerc | Effect of Training Intensity on Nonalcoholic Fatty Liver Disease. | 2015 | Details |
A21096 | 25537957 | J Gastrointest Surg | Bariatric surgery improves histological features of nonalcoholic fatty liver disease and liver fibrosis. | 2014 | Details |
A21097 | 25537833 | Diabetologia | Fibroblast growth factor 21 participates in adaptation to endoplasmic reticulum stress and attenuates obesity-induced hepatic metabolic stress. | 2014 | Details |
A21098 | 25536650 | Ann Hepatol | Lifestyle changes associated with a new antioxidant formulation in non-alcoholic fatty liver disease: a case series. | 2015 | Details |
A21099 | 25536648 | Ann Hepatol | Effects of a low-fat diet on the hepatic expression of adiponectin and its receptors in rats with NAFLD. | 2015 | Details |
A21100 | 25536573 | Probl Radiac Med Radiobiol | Peculiarities of viruses Herpesviridae family persistence in patients with non-alcoholic fatty liver disease who had been exposed to the factors of Chornobyl NPP accident. | 2014 | Details |
A21101 | 25536561 | Probl Radiac Med Radiobiol | Structure of comorbid diseases in patients with non-alcoholic fatty liver disease, exposed to ionizing radiation as a result of the Chornobyl NPP accident. | 2014 | Details |
A21102 | 25535951 | PLoS One | Establishment of a general NAFLD scoring system for rodent models and comparison to human liver pathology. | 2014 | Details |
A21103 | 25534988 | Biochem Pharmacol | The liver-selective NO donor, V-PYRRO/NO, protects against liver steatosis and improves postprandial glucose tolerance in mice fed high fat diet. | 2014 | Details |
A21104 | 25534442 | Life Sci | Role of physical exercise on hepatic insulin, glucocorticoid and inflammatory signaling pathways in an animal model of non-alcoholic steatohepatitis. | 2014 | Details |
A21105 | 25534430 | Amino Acids | Branched chain amino acid metabolism profiles in progressive human nonalcoholic fatty liver disease. | 2014 | Details |
A21106 | 25534427 | Mol Cell Endocrinol | Down-regulation of miR-144 elicits proinflammatory cytokine production by targeting toll-like receptor 2 in nonalcoholic steatohepatitis of high-fat-diet-induced metabolic syndrome E3 rats. | 2014 | Details |
A21107 | 25533546 | Exp Mol Pathol | The importance of the interaction between hepatocyte and hepatic stellate cells in fibrogenesis induced by fatty accumulation. | 2014 | Details |
A21108 | 25533429 | Eur J Gastroenterol Hepatol | Effects of ursodeoxycholic acid therapy on carotid intima media thickness, apolipoprotein A1, apolipoprotein B, and apolipoprotein B/A1 ratio in nonalcoholic steatohepatitis. | 2015 | Details |
A21109 | 25533197 | Liver Int | Ketone body production is differentially altered in steatosis and non-alcoholic steatohepatitis in obese humans. | 2015 | Details |
A21110 | 25533124 | Biochim Biophys Acta | Steatogenesis in adult-onset type II citrullinemia is associated with down-regulation of PPARα. | 2014 | Details |
A21111 | 25533006 | Nutrients | Simple sugar intake and hepatocellular carcinoma: epidemiological and mechanistic insight. | 2014 | Details |
A21112 | 25533004 | Nutrients | Does vitamin C deficiency promote fatty liver disease development? | 2014 | Details |
A21113 | 25532375 | Zhongguo Zhong Yao Za Zhi | [Clinical characteristics and combined use of medicine analysis of 2 991 hospitalized patients with psoriasis based on real world database]. | 2014 | Details |
A21114 | 25532016 | PLoS One | Normocaloric low cholesterol diet modulates Th17/Treg balance in patients with chronic hepatitis C virus infection. | 2014 | Details |
A21115 | 25532002 | J Gastrointestin Liver Dis | Non-invasive biomarkers in non-alcoholic steatohepatitis-induced hepatocellular carcinoma. | 2014 | Details |
A21116 | 25531861 | Endocr Res | Free triiodothyronine levels are positively associated with non-alcoholic fatty liver disease in euthyroid middle-aged subjects. | 2014 | Details |
A21117 | 25531383 | Zhonghua Gan Zang Bing Za Zhi | [Liraglutide protects against nonalcoholic fatty liver disease in ApoE knockout mice with high-fat diet and silenced Acrp30 by increasing AMPK]. | 2014 | Details |
A21118 | 25530013 | Nutr Res | Blood redox status is associated with the likelihood of nonalcoholic fatty liver disease irrespectively of diet's total antioxidant capacity. | 2014 | Details |
A21119 | 25529941 | Hepatology | Magnetic resonance imaging and liver histology as biomarkers of hepatic steatosis in children with nonalcoholic fatty liver disease. | 2015 | Details |
A21122 | 25528857 | Lik Sprava | [Hyperhomocysteinemia--a predictor of inflammatory changes in the liver]. | 2014 | Details |
A21123 | 25528845 | Lik Sprava | [Negative effects of termination statinotherapy in patients after acute coronary event with concominent non-alcoholic steatohepatitis]. | 2014 | Details |
A21124 | 25528832 | Lik Sprava | [CORRECTION OF BILE FLOW CHARACTERISTICS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE IN COMBINATION WITH HYPERURICEMIA]. | 2014 | Details |
A21125 | 25527748 | Am J Clin Nutr | Palmitoleic acid is elevated in fatty liver disease and reflects hepatic lipogenesis. | 2014 | Details |
A21126 | 25526792 | BMJ Open | Effects of lixisenatide on elevated liver transaminases: systematic review with individual patient data meta-analysis of randomised controlled trials on patients with type 2 diabetes. | 2014 | Details |
A21127 | 25526666 | Exp Mol Pathol | Levels of metacaspase1 and chaperones related to protein quality control in alcoholic and nonalcoholic steatohepatitis. | 2014 | Details |
A21128 | 25526027 | Oncotarget | Wnt signaling, de novo lipogenesis, adipogenesis and ectopic fat. | 2014 | Details |
A21129 | 25525637 | Drugs Today (Barc) | A report from The Liver Meeting 2014 (November 7-11 - Boston, Massachusetts, USA). | 2014 | Details |
A21130 | 25525520 | Int J Hepatol | Central portalization correlates with fibrosis but not with risk factors for nonalcoholic steatohepatitis in steatotic chronic hepatitis C. | 2014 | Details |
A21131 | 25524812 | Liver Int | Application of hepatocellular carcinoma surveillance in a European setting. What can we learn from clinical practice? | 2015 | Details |
A21132 | 25524630 | J Nutr Biochem | Oral exposure to the anti-pyridoxine compound 1-amino D-proline further perturbs homocysteine metabolism through the transsulfuration pathway in moderately vitamin B₆ deficient rats. | 2014 | Details |
A21133 | 25524401 | Hepatology | The impact of phlebotomy in nonalcoholic fatty liver disease: A prospective, randomized, controlled trial. | 2015 | Details |
A21135 | 25523099 | Exp Mol Med | Omega-3 polyunsaturated fatty acid and ursodeoxycholic acid have an additive effect in attenuating diet-induced nonalcoholic steatohepatitis in mice. | 2014 | Details |
A21136 | 25522725 | J Am Soc Mass Spectrom | The use of random projections for the analysis of mass spectrometry imaging data. | 2014 | Details |
A21137 | 25522307 | J Pediatr Gastroenterol Nutr | GWAS-Identified Common Variants With Nonalcoholic Fatty Liver Disease in Chinese Children. | 2015 | Details |
A21138 | 25521620 | Obesity (Silver Spring) | Earlier menarche is associated with fatty liver and abdominal ectopic fat in midlife, independent of young adult BMI: The CARDIA study. | 2014 | Details |
A21139 | 25521607 | Aliment Pharmacol Ther | The prevalence of NAFLD and NASH among patients with psoriasis in a tertiary care dermatology and rheumatology clinic. | 2014 | Details |
A21140 | 25520925 | Biomedicine (Taipei) | Auricularia polytricha aqueous extract supplementation decreases hepatic lipid accumulation and improves antioxidative status in animal model of nonalcoholic fatty liver. | 2014 | Details |
A21141 | 25520429 | J Lipid Res | Cholesterol-lowering drugs cause dissolution of cholesterol crystals and disperse Kupffer cell crown-like structures during resolution of NASH. | 2014 | Details |
A21142 | 25518481 | Eksp Klin Gastroenterol | [Possibilities of using the noninvasive methods of investigating the morphofunctional changes in the liver in patients with non alcoholic steatohepatitis and type 2 diabetes mellitus]. | 2014 | Details |
A21143 | 25516477 | Metabolism | The role of fibroblast growth factor 21 in the pathogenesis of non-alcoholic fatty liver disease and implications for therapy. | 2014 | Details |
A21144 | 25516385 | J Gastroenterol | The association between retinal microvascular changes, metabolic risk factors, and liver histology in pediatric patients with non-alcoholic fatty liver disease (NAFLD). | 2014 | Details |
A21145 | 25514917 | Rev Recent Clin Trials | Non-invasive assessment of non-alcoholic fatty liver disease: ultrasound and transient elastography. | 2014 | Details |
A21146 | 25514916 | Rev Recent Clin Trials | Non alcoholic fatty liver: epidemiology and natural history. | 2014 | Details |
A21147 | 25514915 | Rev Recent Clin Trials | Treatment strategies for fatty liver diseases. | 2014 | Details |
A21148 | 25514914 | Rev Recent Clin Trials | Phytotherapy and NAFLD--from goals and challenges to clinical practice. | 2014 | Details |
A21149 | 25514913 | Rev Recent Clin Trials | Orthotopic liver transplantation in non-alcoholic fatty liver disease patients. | 2014 | Details |
A21150 | 25514912 | Rev Recent Clin Trials | Use of liver breath tests to assess severity of nonalcoholic fatty liver disease. | 2014 | Details |
A21151 | 25514911 | Rev Recent Clin Trials | Intestinal permeability in non-alcoholic fatty liver disease: the gut-liver axis. | 2014 | Details |
A21152 | 25514910 | Rev Recent Clin Trials | Common features of the metabolic syndrome and nonalcoholic fatty liver disease. | 2014 | Details |
A21153 | 25514909 | Rev Recent Clin Trials | Role of adipokines and cytokines in non-alcoholic fatty liver disease. | 2014 | Details |
A21154 | 25514908 | Rev Recent Clin Trials | The role of liver biopsy to assess non-alcoholic fatty liver disease. | 2014 | Details |
A21155 | 25514907 | Rev Recent Clin Trials | Insulin resistance, non-alcoholic fatty liver disease and hepatitis C virus infection. | 2014 | Details |
A21156 | 25514555 | J Hepatol | Mirtoselect, an anthocyanin-rich bilberry extract, attenuates non-alcoholic steatohepatitis and associated fibrosis in ApoE(∗)3Leiden mice. | 2014 | Details |
A21157 | 25514415 | Int J Mol Sci | Irisin, a link among fatty liver disease, physical inactivity and insulin resistance. | 2014 | Details |
A21158 | 25514388 | Nutrients | The role of dietary sugars and de novo lipogenesis in non-alcoholic fatty liver disease. | 2014 | Details |
A21159 | 25513983 | Menopause | Prevalence of nonalcoholic fatty liver disease and its metabolic risk factors in women of different ages and body mass index. | 2015 | Details |
A21160 | 25512910 | Biomed Res Int | Uncoupling protein 2 regulates palmitic acid-induced hepatoma cell autophagy. | 2014 | Details |
A21161 | 25512797 | World J Diabetes | Nonalcoholic steatohepatitis and insulin resistance in children. | 2014 | Details |
A21162 | 25512370 | J Pharmacol Exp Ther | Mechanistic basis of altered morphine disposition in nonalcoholic steatohepatitis. | 2014 | Details |
A21163 | 25512222 | BMC Gastroenterol | Expression of NALPs in adipose and the fibrotic progression of non-alcoholic fatty liver disease in obese subjects. | 2014 | Details |
A21164 | 25510350 | Clin Endocrinol (Oxf) | Nonalcoholic fatty liver disease and age are strong indicators for atherosclerosis in morbid obesity. | 2015 | Details |
A21165 | 25509904 | Ter Arkh | [[Current approaches to diagnosing and treating nonalcoholic fatty liver disease]. | 2014 | Details |
A21166 | 25509888 | Ter Arkh | [Adiponectin and parameters of glucose and lipid metabolism at different clinical and morphological stages of non-alcoholic fatty liver disease in patients with abdominal obesity]. | 2014 | Details |
A21167 | 25506780 | JAMA Pediatr | Nonalcoholic fatty liver disease: a challenge for pediatricians. | 2015 | Details |
A21168 | 25504628 | Mol Nutr Food Res | A weekly alternating diet between caloric restriction and medium fat protects the liver from fatty liver development in middle-aged C57BL/6J mice. | 2015 | Details |
A21171 | 25502558 | PLoS One | A model of metabolic syndrome and related diseases with intestinal endotoxemia in rats fed a high fat and high sucrose diet. | 2014 | Details |
A21172 | 25501551 | Am J Physiol Gastrointest Liver Physiol | Micro-RNA 21 inhibition of SMAD7 enhances fibrogenesis via leptin-mediated NADPH oxidase in experimental and human nonalcoholic steatohepatitis. | 2014 | Details |
A21173 | 25501226 | Genet Mol Res | Correlation between MTP -493G>T polymorphism and non-alcoholic fatty liver disease risk: a meta-analysis. | 2014 | Details |
A21174 | 25500885 | J Clin Invest | Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease. | 2014 | Details |
A21175 | 25500875 | Acta Pharmacol Sin | Farnesoid X receptor: a master regulator of hepatic triglyceride and glucose homeostasis. | 2014 | Details |
A21176 | 25500721 | J Hepatol | Age at menarche and non-alcoholic fatty liver disease. | 2014 | Details |
A21177 | 25500563 | PLoS Comput Biol | SteatoNet: the first integrated human metabolic model with multi-layered regulation to investigate liver-associated pathologies. | 2014 | Details |
A21178 | 25499943 | J Clin Lipidol | Liver histology during Mipomersen therapy for severe hypercholesterolemia. | 2014 | Details |
A21179 | 25496866 | Zhonghua Gan Zang Bing Za Zhi | [Influence of GLP-1 on oxidative stress injury in non-alcoholic fatty liver disease rats]. | 2014 | Details |
A21180 | 25496394 | BMC Gastroenterol | Non-alcoholic fatty liver disease associated with gallstones in females rather than males: a longitudinal cohort study in Chinese urban population. | 2014 | Details |
A21181 | 25496369 | Aliment Pharmacol Ther | Clinical, biochemical and histological differences between HIV-associated NAFLD and primary NAFLD: a case-control study. | 2014 | Details |
A21182 | 25495478 | Liver Int | Non-invasive score system for fibrosis in chronic hepatitis: proposal for a model based on biochemical, FibroScan and ultrasound data. | 2015 | Details |
A21183 | 25495373 | Liver Int | ELF score ≥9.8 indicates advanced hepatic fibrosis and is influenced by age, steatosis and histological activity. | 2015 | Details |
A21184 | 25493326 | Can J Physiol Pharmacol | The CBS/CSE system: a potential therapeutic target in NAFLD? | 2015 | Details |
A21185 | 25493023 | World J Gastroenterol | Increased circulating zonulin in children with biopsy-proven nonalcoholic fatty liver disease. | 2014 | Details |
A21186 | 25493022 | World J Gastroenterol | Resistant mutants induced by adefovir dipivoxil in hepatitis B virus isolates. | 2014 | Details |
A21187 | 25492998 | World J Gastroenterol | Focus on emerging drugs for the treatment of patients with non-alcoholic fatty liver disease. | 2014 | Details |